Aidapak Recalls Trihexyphenidyl Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling Trihexyphenidyl HCL tablets because they may have been mislabeled as Perphenazine tablets.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II and involves a labeling error (label mixup) without reported injuries or illnesses, fitting the criteria for moderate severity.
Plain-English summary
Aidapak Services, LLC is recalling Trihexyphenidyl HCL tablets, 1 mg (1/2 of 2 mg), NDC 00591533501. The recall is due to a labeling error where the product may have been mislabeled as Perphenazine tablets, 16 mg, NDC 00781104901.
The affected Trihexyphenidyl HCL tablets have the pedigree AD73525_34 and an expiration date of 5/30/2014. The repacked drugs were distributed in Arizona, California, Oregon, and Washington.
Consumers should check their medication for the specific NDC and pedigree codes listed above. If the medication matches the recalled product, they should stop using it and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- TRIHEXYPHENIDYL HCL, Tablet, 1 mg (1/2 of 2 mg), Rx only, Distributed by: AidaPak Service, LLC, NDC 00591533501.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 200
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (4)
- TRIHEXYPHENIDYL HCL
- Tablet
- 1 mg (1/2 of 2 mg) has the following codes: Pedigree: AD73525_34
- EXP: 5/30/2014.
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- SevereImperio Distribution Recalls Beef Jerky Produced Without Federal Inspection
USDA FSIS · 2026-10-24
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- ModerateAidapak Recalls Trimethobenzamide Capsules Due to Potential Label Mixup
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pramipexole Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Benazepril HCL Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-22
- SevereFDA Recalls Tizanidine Tablets Due to Potential Labeling Error
FDA (Drugs) · 2014-01-22
- ModerateAidapak Recalls Pyridoxine HCL Tablets Due to Labeling Mixup
FDA (Drugs) · 2014-01-22
- ModeratePromethazine HCL Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-22